A citation-based method for searching scientific literature

C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
Times Cited: 114







List of co-cited articles
664 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
43

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
281
28

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
24

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
270
23

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
22

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
21

Sociocultural influences on participation in genetic risk assessment and testing among African American women.
Chanita Hughes, Grace Ann Fasaye, V Holland LaSalle, Clinton Finch. Patient Educ Couns 2003
74
28


Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
625
19

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
425
17

The association between race and attitudes about predictive genetic testing.
Nikki Peters, Abigail Rose, Katrina Armstrong. Cancer Epidemiol Biomarkers Prev 2004
88
19



The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
16

Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
345
16

Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
Q Gao, G Tomlinson, S Das, S Cummings, L Sveen, J Fackenthal, P Schumm, O I Olopade. Hum Genet 2000
79
20


Ethnic differences in risk perception among women at increased risk for breast cancer.
C Hughes, C Lerman, E Lustbader. Breast Cancer Res Treat 1996
114
15

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
15

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F J Couch, M L DeShano, M A Blackwood, K Calzone, J Stopfer, L Campeau, A Ganguly, T Rebbeck, B L Weber. N Engl J Med 1997
520
15




Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
13

Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
M D Schwartz, C Hughes, J Roth, D Main, B N Peshkin, C Isaacs, C Kavanagh, C Lerman. Cancer Epidemiol Biomarkers Prev 2000
80
16

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
388
13

Breast cancer risk counseling improves women's functioning.
Deborah J Bowen, Wylie Burke, Anne McTiernan, Yutaka Yasui, M Robyn Andersen. Patient Educ Couns 2004
53
24

Application of breast cancer risk prediction models in clinical practice.
Susan M Domchek, Andrea Eisen, Kathleen Calzone, Jill Stopfer, Anne Blackwood, Barbara L Weber. J Clin Oncol 2003
124
12


Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer.
Lisa Kessler, Aliya Collier, Kiyona Brewster, ChaChira Smith, Benita Weathers, E Paul Wileyto, Chanita Hughes Halbert. Genet Med 2005
48
25

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen,[...]. JAMA 2005
171
12

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
102
11

Genetic counseling for women with an intermediate family history of breast cancer.
W Burke, J O Culver, D Bowen, D Lowry, S Durfy, A McTiernan, M R Andersen. Am J Med Genet 2000
75
14

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
475
11

Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.
Deborah J Bowen, Wylie Burke, Yutaka Yasui, Anne McTiernan, Dale McLeran. Genet Med 2002
28
39

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
91
10

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
91
10

The use of videotaped information in cancer genetic counselling: a randomized evaluation study.
A Cull, H Miller, T Porterfield, J Mackay, E D Anderson, C M Steel, R A Elton. Br J Cancer 1998
96
10

BRCA1 mutations in African Americans.
R C Panguluri, L C Brody, R Modali, K Utley, L Adams-Campbell, A A Day, C Whitfield-Broome, G M Dunston. Hum Genet 1999
56
17


Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.
Chanita Hughes Halbert, Lisa Kessler, Jill E Stopfer, Susan Domchek, E Paul Wileyto. Genet Med 2006
51
19

Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
430
9

Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer.
D R Lannin, H F Mathews, J Mitchell, M S Swanson, F H Swanson, M S Edwards. JAMA 1998
486
9

Family history of breast cancer: what do women understand and recall about their genetic risk?
M Watson, V Duvivier, M Wade Walsh, S Ashley, J Davidson, M Papaikonomou, V Murday, N Sacks, R Eeles. J Med Genet 1998
108
9

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
9


Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
695
9

Minority recruitment in hereditary breast cancer research.
Chanita Hughes, Susan K Peterson, Amelie Ramirez, Kipling J Gallion, Paige Green McDonald, Celette Sugg Skinner, Deborah Bowen. Cancer Epidemiol Biomarkers Prev 2004
45
20

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.